.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent clinical findings highlight the potential of vaginal PRP injection as a therapeutic option for enhancing sexual health in women. Furthermore, a pilot randomized controlled trial (RCT) recently published in Obstetrics & Gynecology evaluated 52 premenopausal women. Specifically, researchers compared a one-time anterior vaginal wall injection of platelet-rich plasma (PRP) to a saline placebo.
Consequently, the study found that women treated with PRP experienced a significantly greater increase in their total Female Sexual Function Index (FSFI) scores. Moreover, at the six-week mark, the PRP group showed a median score change of 2.2 compared to only 0.3 in the control group. This improvement remained visible at the six-month follow-up. However, while subscale scores for desire, arousal, and lubrication improved, these specific changes did not reach statistical significance against the control. Additionally, nearly 70% of the PRP group reported overall improvement on the Patient Global Impression of Improvement (PGI-I) scale. Therefore, this suggests that the procedure is not only effective but also yields high patient satisfaction. Finally, clinicians reported no serious adverse events, confirming a favorable safety profile.
Platelet-rich plasma contains concentrated growth factors that stimulate tissue regeneration, improve blood flow, and enhance nerve sensitivity in the vaginal wall.
Yes, the latest clinical data indicates that the procedure is well-tolerated. In the randomized trial, participants reported no serious adverse events over a six-month period.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Clarke B et al. Vaginal Injection of Platelet-Rich Plasma for Sexual Function: A Randomized Controlled Trial. Obstet Gynecol. 2026 Mar 19. doi: 10.1097/AOG.0000000000006256. PMID: 41855531.
2. De Ponte A et al. Platelet-rich plasma in the management of vulvovaginal disorders: a systematic review. J Sex Med. 2026 Jan 5;23(1):qdaf307. doi: 10.1093/jsxmed/qdaf307. PMID: 41168677.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A recent RCT demonstrates that vaginal PRP injections significantly improve sexual function scores and patient satisfaction in premenopausal women....
4 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
